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Abstract To investigate the influence of NF-jB antisense
oligonucleotide on transdifferentiation of fibroblast in the
pathological process of bleomycin-induced pulmonary
fibrosis in mice. 6 h before molding of C57BL/6 model of
pulmonary fibrosis in mice, NF-jB antisense oligonucleotide
was injected from caudal vein. Then the lung tissue was
collected for primary culture as well as model group and
control group. Cultured cells were used for immunocyto-
chemical staining of p65, IjB-a and a-SMA proteins as well
as in situ hybridization staining of p65 and IjB-a. Then image
analysis was carried out. The expressions of all the indicators
were expressed as mean optical density. Compared with the
control group, the expressions of p65 protein, IjB-a protein
and a-SMA protein of model group were increased, as well as
the expressions of p65 mRNA and IjB-a mRNA (P \ 0.05).
Compared with model group, the expressions of all indicators
of intervention group were decreased (P \ 0.05). P65 protein
and p65 mRNA were positively correlated with the expression
of a-SMA protein respectively. p65 protein and p65 mRNA
were positively correlated with the expressions of IjB-a
protein and IjB-a mRNA respectively. NF-jB antisense
oligonucleotide can inhibit the transdifferentiation of fibro-
blast towards myofibroblast in the pathological process of
bleomycin-induced pulmonary fibrosis in mice.
Keywords Fibroblast  Myofibroblast  NF-jB  IkB-a 
a-SMA  NF-jB antisense oligonucleotide
Introduction
Idiopathic pulmonary fibrosis (IPF) is a disease whose path-
ogenesis is not clear yet. The fibroblast (Fb) attracts much
attention because of its participation in the generation of
extracellular matrix. The myofibroblast (MF) is a special kind
of Fb. Compared with normal Fbs, the ability of MF to secrete
extracellular matrix is obviously enhanced [1]. The a-smooth
muscle actin (a-SMA) is considered to be the most important
specific marker [2]. Currently, researches showed that, in IPE
pathological process, Fbs can transform into MFs under the
effects of multiple cytokines. However, the regulatory
mechanism of this phenotypic transformation still remains to
be further studied. Studies have shown that TGF-b1 can
regulate the proliferation of smooth muscle cell and induce FB
to transform into MF. Other cytokines, such as connective
tissue growth factor (CTGF), interleukin-4 (IL-4), interleu-
kin-13 (IL-13) and endothelin etc., can cooperate with TGF-b
to promote MF generation or proliferation, which, therefore,
leads to pulmonary fibrosis [3]. NF-jB regulates gene tran-
scription of a variety of inflammatory factors and plays a
central role in the regulation of inflammatory response. P65 is
an important functional subunit of NF-jB. NF-jB exists in the
cytoplasm in the non-activated state, combined with an arr-
estin IjB. When the cells are stimulated, IjB is rapidly
degraded by protein kinase. Therefore, NF-jB is separated
and activated. Activated NF-jB enters the nucleus and binds
to the promoter region of target gene, which activates the
target gene and its transcription.
Our previous studies have shown that the expression of p65
in macrophages significantly increases in bleomycin-induced
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mouse model of IPF. P65 antisense oligonucleotide not only
significantly alleviates the mortality and weight loss of the test
mice, but also obviously inhibits the increase of TNF-a in
BALF and serum. In addition, it inhibits the formation of
pulmonary fibrosis and the generation of hydroxyproline [4].
In order to investigate the effect of NF-jB/IjB on phe-
notypic transdifferentiation of Fb towards MF and the inbib-
itional effect of p65 antisense oligonucleotide on NF-jB in
that transdifferentiation in pathological process of IPF, this
experiment was performed. P65 antisense oligonucleotide
was used for the intervention in pathological processes of
bleomycin-induced pulmonary fibrosis in mice. The expres-
sions of p65, IjB-a and a-SMA as well as their correlations in
lung tissue cultured cells were studied. It was found in this
research that p65 antisense oligonucleotide could be swal-
lowed by MFs without any specific vectors (viruses, lipo-
somes and etc.) or gene transfection and it prevented the
fibrosis process and thus improved the survival rate of bleo-
mycin-induced fibrosis in mice. It suggests that NF-jB anti-





C57BL/6 female mice were purchased from Beijing Vital
River Laboratory Animal Technology Company, weighed
from 18 to 20 g, in SPF grad.
Reagents
Bleomycin A2: Nippon Kayaku Co., Ltd., batch number:
Y60520.
Primary antibodies were mouse anti-human p65, IjB-a
and a-SMA monoclonal IgG antibodies: bought from Santa
Cruz Biotechnology, Inc. The secondary antibody was biotin-
labeled goat anti-mouse IgG. Immunohistochemistry kit was
purchased from Beijing Zhongshan Golden Bridge Biotech-
nology Co., Ltd. P65 and IjB-a in situ hybridization kits:
purchased from Wuhan Boster Biological Technology Co.,
Ltd.
Methods
Grouping and processing of laboratory animals
The mice were randomly divided into three groups. There
were six mice in each group. Model group: bleomycin A2
(5 mg/kg, dissolved in 20 ll sterile normal saline) was
instilled in trachea; control group: 20 ll of normal saline
was installed in trachea. Intervention group: NF-jB anti-
sense oligonucleotide was injected from caudal vein 6 h
before modeling. Mice in model group and control group
were injected with 200 ll of normal saline from caudal
vein.
Primary culture and passage of lung tissue
Three mice in each group were selected randomly on the first
day after intratracheal injection as well as the third day. The
mice were executed by cervical vertebra luxation. Lung tissue
was collected under sterile condition and cut into approxi-
mately 2 9 2 mm tissue blocks. They were washed with PBS
for three times and then spread on the bottom of culture flask,
followed by primary culture at 37 C in 5 % CO2. The culture
medium was RPMI-1640 culture medium containing 20 %
fetal bovine serum, 100 u/ml of penicillin and 100 u/ml of
streptomycin. The medium was changed every 2–3 days. Cell
monolayer could form around tissue blocks in 1–2 weeks.
0.25 % trypsin was used for digestion and then the cells were
filled in two culture flasks for passage (1:2). Cells were pas-
saged 3 times with this method. The 4th generation was
transferred from culture flasks to six-well plates carpeted with
coverslips. When the coverslips were covered with cells,
various indicators could be detected.
Identification of fibroblasts
The cultured monolayer cells were fixed with 4 % para-
formaldehyde, followed by immunocytochemical staining
of vimentin and cytokeratin.
Observation of phagocytosis of NF-jB antisense
oligonucleotide by fibroblasts
Fluorescently-labeled p65 antisense oligonucleotide (50-
GAAACAGATCGTCCATGGT-30) was added to the cul-
tured cells, followed by culture for 12 and 24 h. Then the
condition of phagocytosis of NF-jB antisense oligonu-
cleotide by Fbs was observed under inverted fluorescence
microscope (OLYMPUS BX51, Japan).
Immunocytochemical staining
The cultured monolayer cells were fixed with 4 % para-
formaldehyde, followed by immunocytochemical staining
of p65, IjB-a and a-SMA. Dilution ratios of primary
antibodies were all 1:100. As a negative control, PBS was
used instead of primary antibodies. Operations were per-
formed according to immunohistochemistry kit steps. Di-
aminobenzidine (DAB) was used for developing.
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In situ hybridization staining of P65 and IjB-a
The fixative was 4 % paraformaldehyde/0.1 M PBS
(PH7.2-7.6), including 1/1000 DEPC. As a negative con-
trol, PBS was used instead of the probe. The operations
were performed according to in situ hybridization kit steps.
Image acquisition and statistical analysis
5 images of each slide covered with cultured cells were
taken under a microscope (4009) with microscopic image
analysis system (MetaMorph/Evolution Mp 5.0/
BX51;UIC/OLYMPUS,US/JP). The amount of p65, IjB-a
and a-SMA were expressed as mean optical density
(MOD). The mean was used for each slide. SPSS13.0 was
used for statistical processing. All measurement data were
expressed as x ± s and used for statistics. Total differences
of mean between groups were compared by one-way
ANOVA. Every two groups were compared by t test.
Correlation analysis method was used for the statistics of
correlation degree between variables. The inspection level
a = 0.05.
Results
The comparison of p65 protein expressions in cultured
cells from lung tissues of mice in the three groups
The relatively less p65 protein was expressed in cultured
cells from lung tissue of mice in control group (Fig. 1b), and
the MOD value was (0.0421 ± 0.0121); compared with the
negative control (0.0385 ± 0.0047), the difference was not
statistically significant (t = 1.734, P [ 0.05). It shows that
there is no obvious expression of NF-jB in cultured cells
from lung tissue of normal mice. There was relatively more
expression of p65 protein in cultured cells from lung tissue of
mice in model group. The protein was distributed in the
cytoplasm and (or) the nucleus and obvious positive staining
was shown in the nucleus part (Fig. 1a). The MOD value was
(0.1055 ± 0.0407). Compared with control group, the
enhancement was significant (t = 9.449, P \ 0.05). It
indicates that NF-jB protein expression in cultured cells
from lung tissue was significantly enhanced after intratra-
cheal instillation of BLM. Compared with experimental
group, p65 positive staining intensity in intervention group
was obviously reduced. However, compared with control
group, it was obviously enhanced (Fig. 1c). The MOD value
was (0.0774 ± 0.0215). Compared with model group
(t = 3.866, P \ 0.05) and control group (t = 9.031,
P \ 0.05), the differences were significant respectively. It
indicates that intravenous injection of p65 antisense oligo-
nucleotide can obviously inhibit the increase of NF-jB
expression caused by BLM, but the inhibition is not
complete.
The comparison of p65 mRNA expressions in cultured
cells from lung tissues of mice in the three groups
The positive signal of p65 mRNA existed in the cytoplasm.
Part of cytoplasm in cultured cells from lung tissue of mice
in control group was pale brownish-yellow (Fig. 2b). The
MOD value was (0.0613 ± 0.0135). Compared with neg-
ative control group (0.0568 ± 0.0101), the difference was
not statistically significant (t = 1.674, P [ 0.05). It indi-
cates that there is no obvious NF-jB mRNA expression in
cultured cells from lung tissue of normal mice. Compared
with control group, positive signal expression of p65
mRNA in cytoplasm of cultured cells from lung tissue of
mice in model group was obviously enhanced (Fig. 2a).
The manifestation was claybank particles, which showed
irregular filamentous shape, massive shape or cyclic shape.
The MOD value was (0.1611 ± 0.0281). The difference
between the two groups was statistically significant
(t = 20.287, P \ 0.05). It indicates that the expression of
NF-jB mRNA in cultured cells from lung tissue was
obviously enhanced after intratracheal instillation of BLM.
Compared with experimental group, positive staining
intensity of p65 mRNA in intervention group was obvi-
ously reduced. However, compared with control group, that
was obviously enhanced (Fig. 2c). The MOD value was
(0.1003 ± 0.0178). Compared with model group
(t = 11.584, P \ 0.05) and control group (t = 11.048,
P \ 0.05), the differences were statistically significant,
respectively. It indicates that intravenous injection of p65
antisense oligonucleotide can obviously inhibit the increase
of NF-jB mRNA expression caused by BLM, but the
inhibition is not complete.
The comparison of IjB-a protein expressions
in cultured cells from lung tissues of mice in the three
groups
The positive expression of IjB-a protein existed in the
cytoplasm. There was a little or no brownish-yellow fine
particle deposition in the cytoplasm of lung Fbs of mice in
control group cultured in vitro. There was an extremely weak
expression or no expression of IjB-a protein (Fig. 1e).The
MOD value was (0.0342 ± 0.0034). Compared with negative
control (0.0327 ± 0.0045), the difference was not statistically
significant (t = 1.740, P [ 0.05). That indicates that there is
no obvious expression of IjB-a protein in cultured cells from
lung tissue of normal mice. There were relatively more fine
particles in the cytoplasm of lung Fbs of mice in model group
(Fig. 1d). The MOD value was (0.0886 ± 0.0054). Com-
pared with control group, the difference was statistically
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significant (t = 53.867, P \ 0.05). That indicates that IjB-a
protein expression in cultured cells from lung tissue was
obviously enhanced after intratracheal instillation of BLM.
Compared with experimental group, positive staining inten-
sity in intervention group was obviously reduced. However,
compared with control group, that was obviously enhanced
(Fig. 1f). The MOD value was (0.0614 ± 0.0032). Compared
with model group (t = 27.243, P \ 0.05) and control group
(t = 36.824, P \ 0.05), the differences were statistically
significant, respectively. It indicates that intravenous injection
of p65 antisense oligonucleotide can obviously inhibit the
increase of IjB-a protein expression caused by BLM, but the
inhibition is not complete.
The comparison of IjB-a mRNA expressions
in cultured cells from lung tissues of mice in the three
groups
The results from in situ hybridization detection showed that
relatively intensive brownish-yellow particle deposition
existed in the cytoplasm of lung Fbs of mice in model
group (Fig. 2d). The MOD value was (0.1525 ± 0.0239).
Obviously less brownish-yellow particles existed in the
cytoplasm of lung Fbs in control group (Fig. 2e). The
MOD value was (0.0658 ± 0.0146). The difference
between the two groups was statistically significant
(t = 19.579, P \ 0.05). That indicates that IjB-a mRNA
Fig. 1 Immunocytochemical staining of p65, IjB-a, and a-SMA in
model group, control group, and intervention group. a Immunocyto-
chemical staining of p65 in model group. Darker staining in cytoplasm
and more staining in nucleus were observed (9400). b Immunocyto-
chemical staining of p65 in control group. Lighter staining in cytoplasm
and rare staining in nucleus were observed (9400). c Immunocyto-
chemical staining of p65 in intervention group. Compared with model
group, positive staining intensity was obviously reduced; compared
with control group, positive staining intensity was obviously enhanced
(9400). d Immunocytochemical staining of IjB-a in model group.
Relatively more brownish-yellow fine particles in cytoplasm were
observed (9400). e Immunocytochemical staining of IjB-a in control
group. A few or no brownish-yellow fine particle in cytoplasm was
observed (9400). f Immunocytochemical staining of IjB-a in inter-
vention group. Fine particles in cytoplasm were obviously less than
those in model group and more than those in control group (9400).
g Immunocytochemical staining of a-SMA in model group. Filamen-
tous or strip darker brownish-yellow staining positive substance was
evenly distributed in cytoplasm (9400). h Immunocytochemical
staining of a-SMA in control group. Pale brownish-yellow staining
in cytoplasm was observed; positive substance was obviously less than
that in model group (9400). i Immunocytochemical staining of a-SMA
in intervention group. Compared with model group, filamentous or strip
brownish-yellow staining intensity in cytoplasm was obviously
reduced; while that was obviously enhanced, compared with control
group (9400). (Color figure online)
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expression in cultured cells from lung tissue was obviously
enhanced after intratracheal instillation of BLM. The dif-
ference between control group and negative control group
(0.0634 ± 0.0110) was not statistically significant
(t = 0.861, P [ 0.05). That indicates that there is no
obvious IjB-a mRNA expression in cultured cells from
lung tissue of normal mice. Compared with experimental
group, IjB-a mRNA positive staining intensity in inter-
vention group was obviously reduced. However, compared
with control group, that was obviously enhanced (Fig. 2f).
The MOD value was (0.1126 ± 0.0181). Compared with
model group (t = 8.047, P \ 0.05) and control group
(t = 12.715, P \ 0.05), the differences were statistically
significant, respectively. That indicates that intravenous
injection of p65 antisense oligonucleotide can obviously
inhibit the increase of IjB-a mRNA expression caused by
BLM, but the inhibition is not complete.
The comparison of a-SMA protein expressions
in cultured cells from lung tissues of mice in the three
groups
The immunocytochemical staining of a-SMA in cultured
cells from lung tissue of mice in control group showed
obvious positive expression. The manifestation was that fil-
amentous or strip pale brownish-yellow a-SMA expression
positive substance was evenly distributed in the cytoplasm
(Fig. 1h). The MOD value was (0.0661 ± 0.0023). Com-
pared with negative control (0.0368 ± 0.0024), the differ-
ence was statistically significant (t = 55.850, P \ 0.05). It
was observed that the number of positively stained cells in
model group obviously increased and staining intensity was
significantly enhanced compared with the control group
(Fig. 1g). The MOD value was (0.1341 ± 0.0154). Com-
pared with control group, the difference was statistically
significant (t = 27.691, P \ 0.05). That indicates that there is
certain expression of a-SMA in lung tissue of normal mice.
The expression of a-SMA in cells of lung tissue was obviously
enhanced after intratracheal instillation of BLM. It was
observed that positively stained cells in intervention group
was stained lighter (Fig. 1i). The MOD value was
(0.0985 ± 0.0195). Compared with model group, the differ-
ence was statistically significant (t = 9.075, P \ 0.05).
Compared with control group, the difference was also statis-
tically significant (t = 10.424, P \ 0.05). That indicates that
p65 antisense oligonucleotide obviously inhibits the increase
of a-SMA expression caused by BLM, but the inhibition is not
complete.
Fig. 2 The situ hybridization staining results of p65, IjB-a expres-
sion in model group, control group and intervention group. a In situ
hybridization staining of p65 in model group. Darker brownish-
yellow particles in cytoplasm were observed, which showed irregular
filamentous shape, massive shape or cyclic shape (9400). b In situ
hybridization staining of p65 in control group. Part of cytoplasm was
brownish-yellow and stained light (9400). c In situ hybridization
staining of p65 in intervention group. Compared with model group,
positive staining intensity was obviously reduced; while that was
obviously enhanced, compared with control group (9400). d In situ
hybridization staining of IjB-a in model group. There was relatively
intensive brownish-yellow particle deposition in cytoplasm (9400).
e In situ hybridization staining of IjB-a in control group. Compared
with model group, brownish-yellow particles in cytoplasm were
obviously reduced (9400). f In situ hybridization staining of IjB-a in
intervention group. Brownish-yellow particles in cytoplasm were less
than those in model group and more than those in control group
(9400). (Color figure online)
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Correlations among expressions of p65 protein, IjB-a
protein, a-SMA protein, p65 mRNA and IjB-a mRNA
(correlation analysis of the mean of the groups)
The p65 protein was positively correlated with IjB-a
protein expression (r = 0.998, P \ 0.05); p65 protein was
positively correlated with a-SMA protein expression
(r = 0.971, P \ 0.05); p65 mRNA was positively corre-
lated with a-SMA protein expression (r = 0.955,
P \ 0.05); p65 mRNA was positively correlated with IjB-
a mRNA protein expression (r = 0.989, P \ 0.05); the
correlation between IjB-a protein and a-SMA protein was
not statistically significant (r = 0.826, P [ 0.05).
The observation of phagocytosis of NF-jB antisense
oligonucleotide by lung Fbs
The fluorescently-labeled p65 antisense oligonucleotide
was added to cultured cells, followed by culture for 12 h.
Obvious fluorescent developing was observed in Fbs under
fluorescence microscope, mainly in the cytoplasm
(Fig. 3a). After the culture for 24 h, fluorescent developing
was also observed in the nuclei of part of Fbs (Fig. 3b).
Discussion
Pulmonary fibrosis (PF) is a disease whose pathogenesis is
not clear. It lacks an effective treatment. In recent years,
studies have shown that pulmonary fibrosis had a process
of the transformation of pulmonary interstitial Fbs into
MFs accompanied by a large quantity of extracellular
matrix deposition. The appearance and persistence of MFs
played a key role in the formation of PF [5]. At present, the
regulatory mechanism of the transformation of MFs has not
been clear yet.
In order to investigate the effect of NF-jB on the phe-
notypic transformation of lung Fbs in the pathological
process of bleomycin-induced pulmonary fibrosis and
research the preventive effect of NF-jB antisense oligo-
nucleotide on bleomycin-induced pulmonary fibrosis in
mice, primary culture of lung tissues of mice in pulmonary
fibrosis model group and NF-jB antisense oligonucleotide
treatment group was performed. And immunocytochemical
staining and in situ hybridization technology were used. In
addition, the expressions of NF-jB in Fbs in various
groups were compared and the relationship among NF-jB,
IkB-a and a-SMA was studied. In this experiment, tissue
explants adherent method was used for primary culture of
lung Fbs. After 4 generations, immunocytochemical
staining showed that the expression of vimentin was
strongly positive and the expression of keratin was nega-
tive. Therefore, the cells were identified as Fbs. The cul-
tured cells could guarantee the reliability and repeatability
of the experiment (Tables 1, 2).
NF-jB is an important transcription factor and P65 is
the main functional subunit of NF-jB [6]. Non-activated
NF-jB exists in the cytoplasm. When activated, NF-jB
enters the nucleus and binds to the promoter region of the
target gene, which activates the target gene and begins its
transcription.
Lung Fbs can synthesize and secrete a variety of cyto-
kines. Besides, they can synthesize collagen and matrix
proteins. By the secretion of those cytokines, Fbs form an
inflammatory reaction self-excited positive feedback,
which aggravates and extends the disease duration of
fibrosis [7]. After the transformation of Fbs into MFs, the
synthesis and secretion abilities are obviously enhanced.
Meanwhile, the MF has contractile characteristic, which
may change the mechanical characteristics of fibrotic lung
tissue and reduce the compliance of lung. That character-
istic is related to the increase of a-SMA expression [8, 9].
Fig. 3 The observation of phagocytosis of p65 antisense oligonu-
cleotide by fibroblasts. a Fluorescently-labeled p65 antisense oligo-
nucleotide was added to cultured cells, followed by culture for 12 h.
Obvious fluorescent developing in fibroblasts was observed under
fluorescence microscope, mainly in the cytoplasm. b After the culture
for 24 h, fluorescent developing was also observed in nuclei of part of
the fibroblasts
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That whether NF-jB affects the transformation of Fbs into
MFs in the process of BLM-induced lung injury has not
been reported yet. The Fb can synthesize and secrete var-
ious cytokines, thus it is inferred that the expressions of
NF-jB and a-SMA in the Fb may increase in BLM-
induced lung injury. This experiment confirms that
hypothesis. In this research, it was found that the expres-
sions of NF-jB protein and NF-jB mRNA in primarily
cultured lung Fbs of mouse model of pulmonary fibrosis
were obviously enhanced, compared with normal mice.
That suggests that NF-jB may be involved in the process
of the synthesis of certain cytokines in lung Fbs. It was also
found that the number of a-SMA positive cells in lung Fbs
of mice with pulmonary fibrosis cultured in vitro was
obviously more than that of normal mice. That indicates
that the increase of MFs may be closely related to PF.
Therefore, it is inferred that NF-jB expressed in interstitial
cells may achieve its pathological function by regulating
the transformation of fibroblasts into MFs, in the process of
BLM-induced lung injury in mice and the following for-
mation of pulmonary fibrosis.
Firstly, in this experiment, it was verified that the
expression of a-SMA in pulmonary interstitial cells was
obviously increased in the process of BLM-induced lung
injury, which was similar to other research conclusions [8,
10]. Though, it has not been reported so far that NF-jB
directly played a role in the regulation of a-SMA synthesis,
there might be a close relationship between them. TNF-a,
TGF-b, IL- 1b and PDGF etc. can activate lung Fbs and
have chemotactic effect on lung Fbs. In addition, they can
promote the mitosis and stimulate the collagen synthesis of
lung Fbs [11, 12]. When activated, NF-jB is involved in
transcriptional regulation of gene expressions of a variety
of cytokines and inflammatory mediators [13] and the
stimulation of lung Fb hyperplasia [14]. It was also found
in the experiment that p65 protein (r = 0.971, P \ 0.05),
the subunit of NF-jB, and p65 mRNA (r = 0.955,
P \ 0.05) were both positively correlated with the
expression of a-SMA protein in lung Fbs in the process of
bleomycin-induced acute lung injury. According to that, it
is inferred that NF-jB may promote the transformation of
Fbs into MFs by some way to promote pulmonary fibrosis
in the pathological process of pulmonary fibrosis.
Possible mechanism of NF-jB’s promotion of the
transformation of lung Fbs into MFs: After the action of
internal and external stimulation on cells, NF-jB is acti-
vated and then enters the nucleus to regulate the tran-
scription of responsive genes of NF-jB [15]. Many genes
encoding inflammatory molecules and proliferative factors
are the responsive genes of NF-jB. TGF-b1 is the most
important growth factor which induces MF phenotype [16,
17]. Researches at home and abroad confirm that exoge-
nous TGF-b1 can induce the differentiation of human
embryonic lung cells into the MF phenotype, and time and
dose–effect relationship exists [18]. By in vitro experiment,
Vancheri et al. [19] also confirm that TGF-b1, IL-4, IL-13
and bradykinin etc. can induce the differentiation of lung
Fbs into MFs. Some growth factors (such as PDGF,IGF-1
and FGF) can lead to proliferative phenotype of lung Fbs
and fibrosing phenotype eventually, which results in the
differentiation of lung Fbs into MFs. NF-jB promotes the
transformation of lung fibroblasts into MFs by regulating
the transcription of various chemokines, adhesion mole-
cules and growth factors. Myofibroblasts can produce
extracellular matrix and secrete cytokines, growth factors
and inflammatory mediators. Therefore, MFs play an
important role in the formation of pulmonary fibrosis.
In order to further investigate the effect of NF-jB on the
phenotypic transformation of Fbs in the process of BLM-
induced lung injury, activation of NF-jB was blocked by
injection of P65 antisense oligonucleotide from caudal vein
6 h before intratracheal instillation of BLM. The results
showed that P65 antisense oligonucleotide obviously
inhibited the increase of P65 expression caused by BLM in
Table 1 Mean optical density values in the groups with immunocytochemical staining and in situ hybridization staining (mean ± SD)
Group n p65 protein IjB-a protein a-SMA protein p65 mRNA IjB-a mRNA
Model group 40 0.1055 ± 0.0407 0.0886 ± 0.0054 0.1341 ± 0.0154 0.1611 ± 0.0281 0.1525 ± 0.0239
Intervention group 40 0.0774 ± 0.0215 0.0614 ± 0.0032 0.0985 ± 0.0195 0.1003 ± 0.0178 0.1126 ± 0.0181
Control group 40 0.0421 ± 0.0121 0.0342 ± 0.0034 0.0661 ± 0.0023 0.0613 ± 0.0135 0.0658 ± 0.0146
Negative control group 40 0.0385 ± 0.0047 0.0327 ± 0.0045 0.0368 ± 0.0024 0.0568 ± 0.0101 0.0634 ± 0.0110
F 70.289 1565.895 447.445 268.981 234.144
P \0.05 \0.05 \0.05 \0.05 \0.05
Table 2 The correlation coefficients among the mean expressions
Protein IjB-a protei a-SMA protein IjB-a mRNA
p65 protein 0.998# 0.971# ND
IjB-a protein ND 0.826 ND
p65 mRNA ND 0.955# 0.989#
# represents P \ 0.05
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pulmonary interstitial cells. In addition, a-SMA expression
was also obviously inhibited. That further confirms our
speculation, that is, NF-jB may regulate the transformation
of Fbs into MFs through some indirect relationship and this
regulation may play an important role in the pathogenesis
of pulmonary fibrosis.
The activation of NF-jB is regulated by precise mecha-
nisms. Regulation of NF-jB activation includes positive and
negative feedback regulation. Positive feedback regulation
occurs mainly in the extracellular domain, which is the
extracellular mechanism of the amplification of inflammatory
reaction [20, 21]. Negative feedback regulation can inhibit
further activation of NF-jB and limit the continuous expan-
sion of inflammatory reaction [22, 23]. IjB-a is a super
inhibitor of NF-jB. Inhibiting the degradation of IjB-a or
increasing its synthesis can obviously inhibit the activity of
NF-jB [24]. Griesenbach et al. [25] transfect airway epithelial
cells with adenovirus carrying IjB gene, and they find that
directly increasing the expression of IjB in the body can
inhibit the activation of NF-jB and block the synthesis of
inflammatory factors regulated by NF-jB. Then the occur-
rence of lung inflammation is controlled and ALI is cured.
That whether IjB-a played a role in negative feedback reg-
ulation of NF-jB activation has not been reported by relevant
literature yet. It is inferred by us that IjB-a will increase with
the activation of NF-jB and then inhibit the further activation
of NF-jB. Experiment results confirm that speculation. It was
found in this research that the expression of IjB-a in cultured
lung Fbs of model mice was obviously more than that of
normal mice. When the activation of NF-jB was blocked by
P65 antisense oligonucleotide, IjB-a expression decreased.
That suggests that IjB-a’s negative feedback inhibition also
weakens with the weakening of NF-jB activation. Correla-
tion analysis of the indicators was performed. And, it was
found that the mean of NF-jBp65 of all groups was positively
correlated with the means of IjB-a protein expression and
mRNA expression of all groups in primarily cultured lung
Fbs. That suggests that after activation, NF-jB can upregulate
the expression of IjB-a gene. The increase of IjB-a expres-
sion can prevent the excessive increase of NF-jB to achieve
negative feedback regulation. It is found in our previous
studies [2] that the expression of NF-jBp65 in lung Fbs of
model mice with pulmonary fibrosis cultured in vitro reaches
a peak at 24 h and it gradually decreases after that. It is con-
sidered that the result is closely related to IjB-a’s negative
feedback regulation.
The effects of NF-jB antisense oligonucleotide on the
survival of mice with bleomycin-induced pulmonary
fibrosis and phenotypic transformation of cultured Fbs
were studied. In model group, intratracheal instillation of
bleomycin A2 (5 mg/kg) was performed, followed by
observation for 2 weeks. The mortality rate was 20 %
(6/30). In intervention group, NF-jB antisense oligonu-
cleotide was injected from caudal vein 6 h before modeling.
No mice died. It was visible that antisense oligonucleotide
significantly improved the mouse survival rate. The weight
of mice with bleomycin-induced pulmonary fibrosis obvi-
ously increased after intervention of antisense oligonu-
cleotide. It was observed under fluorescence microscope
that there was a large quantity of fluorescently-labeled NF-
jB antisense oligonucleotide in cultured lung Fbs. That
certified that NF-jB antisense oligonucleotide can enter Fbs
by phagocytosis without any specific vector (viruses, lipo-
somes and etc.) or gene transfection. Through immunocy-
tochemical staining, it was further confirmed that antisense
oligonucleotide could inhibit NF-jB, activate the Fbs and
inhibit the transdifferentiation of Fbs into MFs. Those
results indicate that endocytosis of antisense oligonucleo-
tide by activated Fbs can alleviate acute lung injury/fibrosis
and thus improve the survival situation of mice with bleo-
mycin-induced pulmonary fibrosis.
Currently, the main drugs for treatment of pulmonary
fibrosis are corticosteroids and/or immunosuppressants.
Therapeutic effects are limited and side effects are rela-
tively serious. The advantages and disadvantages should be
weighed, when the drugs are used for treatment. Various
attempts are performed on animal models, hoping to find a
more effective drug for treatment of pulmonary fibrosis. In
our experiment, no specific vector was used. Antisense
oligonucleotides entered the activated lung Fbs or were
swallowed by activated lung Fbs. Those antisense oligo-
nucleotides not only prevented the bleomycin-induced
pulmonary fibrosis, but also might be effective on other
kinds of pulmonary fibrosis, including IPF. Our studies
show that NF-jB plays an important role in the patholog-
ical process of pulmonary fibrosis. NF-jB antisense oli-
gonucleotide can inhibit bleomycin-induced acute lung
injury/fibrosis. Therefore, it may become an effective way
of gene therapy. Through animal experiments, it is pri-
marily proved by us that NF-jB antisense oligonucleotide
can inhibit the transdifferentiation of Fbs into MFs and
cure pulmonary fibrosis. However, specific mechanism,
signal transduction pathways, clinical safety and effec-
tiveness need to be further confirmed. It is believed that
with the research of related pathogenesis of immunology
and molecular biology, gene therapy will become a safe
and effective treatment for pulmonary fibrosis.
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